These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 8473891)

  • 1. YM-09151-2 but not l-sulpiride induces transient dopamine release in rat striatum via a tetrodotoxin-insensitive mechanism.
    Tomiyama K; Noguchi M; Koshikawa N; Kobayashi M
    J Neurochem; 1993 May; 60(5):1690-5. PubMed ID: 8473891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo microdialysis evidence for transient dopamine release by benzazepines in rat striatum.
    Tomiyama K; Koshikawa N; Funada K; Oka K; Kobayashi M
    J Neurochem; 1995 Dec; 65(6):2790-5. PubMed ID: 7595579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization and pharmacological responsiveness of dopamine release recorded by microdialysis in the substantia nigra of conscious rats.
    Santiago M; Westerink BH
    J Neurochem; 1991 Sep; 57(3):738-47. PubMed ID: 1677674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of action of methylmercury on in vivo striatal dopamine release. Possible involvement of dopamine transporter.
    Faro LR; do Nascimento JL; Alfonso M; Durán R
    Neurochem Int; 2002 Apr; 40(5):455-65. PubMed ID: 11821154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of adenylate cyclase in the modulation of the release of dopamine: a microdialysis study in the striatum of the rat.
    Santiago M; Westerink BH
    J Neurochem; 1990 Jul; 55(1):169-74. PubMed ID: 1693944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effects of dopamine D1 and D2 receptor antagonists on rat striatal, limbic and nigral dopamine synthesis and utilisation.
    Magnusson O; Mohringe B; Fowler CJ
    J Neural Transm; 1987; 69(3-4):163-77. PubMed ID: 2957465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of the striatal dopaminergic neuron system by carbon monoxide exposure in free-moving rats, as determined by in vivo brain microdialysis.
    Hara S; Mukai T; Kurosaki K; Kuriiwa F; Endo T
    Arch Toxicol; 2002 Oct; 76(10):596-605. PubMed ID: 12373456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-HT3 receptor agonist induced carrier-mediated release of dopamine in rat striatum in vivo.
    Santiago M; Machado A; Cano J
    Br J Pharmacol; 1995 Sep; 116(1):1545-50. PubMed ID: 8564217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does brain 3,4-dihydroxyphenylacetic acid reflect dopamine release?
    Soares-da-Silva P
    J Pharm Pharmacol; 1987 Feb; 39(2):127-9. PubMed ID: 2881997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo characterization of locally applied dopamine uptake inhibitors by striatal microdialysis.
    Nomikos GG; Damsma G; Wenkstern D; Fibiger HC
    Synapse; 1990; 6(1):106-12. PubMed ID: 1697988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of quinine on autoreceptor-regulated dopamine release in the rat striatum.
    Tanaka T; Vincent SR; Nomikos GG; Fibiger HC
    J Neurochem; 1992 Nov; 59(5):1640-5. PubMed ID: 1357098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo mechanisms underlying dopamine release from rat nigrostriatal terminals: I. Studies using veratrine and ouabain.
    Fairbrother IS; Arbuthnott GW; Kelly JS; Butcher SP
    J Neurochem; 1990 Jun; 54(6):1834-43. PubMed ID: 2338544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of nitric oxide donors on endogenous dopamine release from rat striatal slices. II: The role of voltage-dependent sodium channels, calcium channel activation, reverse transport mechanism, guanylate cyclase and endogenous glutamate.
    Büyükuysal RL
    Fundam Clin Pharmacol; 1997; 11(6):528-36. PubMed ID: 9444520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of age and dopamine agonists and antagonists on striatal dopamine release in the rat: an in vivo microdialysis study.
    Santiago M; Machado A; Cano J
    Mech Ageing Dev; 1993 Apr; 67(3):261-7. PubMed ID: 7686993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo mechanisms underlying dopamine release from rat nigrostriatal terminals: II. Studies using potassium and tyramine.
    Fairbrother IS; Arbuthnott GW; Kelly JS; Butcher SP
    J Neurochem; 1990 Jun; 54(6):1844-51. PubMed ID: 2338545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of dopamine release in the substantia nigra by in vivo microdialysis in freely moving rats.
    Robertson GS; Damsma G; Fibiger HC
    J Neurosci; 1991 Jul; 11(7):2209-16. PubMed ID: 1712381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biotransformation of locally applied L-dopa in the corpus striatum of the hemi-parkinsonian rat studied with microdialysis.
    Sarre S; De Klippel N; Herregodts P; Ebinger G; Michotte Y
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Jul; 350(1):15-21. PubMed ID: 7935849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. d-fenfluramine increases striatal extracellular dopamine in vivo independently of serotonergic terminals or dopamine uptake sites.
    De Deurwaerdère P; Bonhomme N; Le Moal M; Spampinato U
    J Neurochem; 1995 Sep; 65(3):1100-8. PubMed ID: 7543929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amphetamine-induced dopamine release in the rat striatum: an in vivo microdialysis study.
    Butcher SP; Fairbrother IS; Kelly JS; Arbuthnott GW
    J Neurochem; 1988 Feb; 50(2):346-55. PubMed ID: 2447237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the synthesis and metabolism of striatal dopamine after disruption of nerve conduction in the medial forebrain bundle.
    Commissiong JW; Slimovitch C; Toffano G
    Br J Pharmacol; 1990 Apr; 99(4):741-9. PubMed ID: 2361171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.